Association of fear assessment in inflammatory rheumatic diseases (FAIR) questionnaire with ankylosing spondylitis quality of life and disease activity in patients with ankylosing spondylitis

Fear assessment questionnaire in ankylosing spondylitis

Authors

Keywords:

Ankylosing spondylitis, Fear, Quality of life, Pain

Abstract

Background/Aim: Fear against disease course, treatment, and limitations in family, work, and social life are commonly seen but mostly overlooked by physicians of patients with chronic inflammatory rheumatic diseases. Ankylosing spondylitis (AS) is a chronic inflammatory disease in young adults characterized by limitations in spinal mobility. The Fear Assessment (FAIR) Questionnaire was designed especially for patients with rheumatoid arthritis and spondyloarthritis to assess the level of fear from the patient’s perspective. Here we evaluate the FAIR score in AS patients and its association with disease activity, AS quality of life (ASQoL), depression, anxiety, and fatigue levels.

Methods: This cross-sectional study included 79 patients with AS, and disease activity was assessed by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), AS-Disease Activity Score-C reactive protein, and functional status was assessed by Bath Ankylosing Spondylitis Functional Index (BASFI). Patient global assessment of disease and pain were scored on 0–10 cm visual analog scores. All patients completed FAIR and ASQoL questionnaires. The depression and anxiety were evaluated by Hospital Anxiety and Depression Scale (HADS), and fatigue was assessed by Fatigue Severity Scale (FSS).

Results: The mean age of AS patients (62% male) was 41.7 (11.3) years. Most of the patients were on biological disease-modifying anti-rheumatic drugs (bDMARDs). The patients’ median BASDAI, ASDAS-CRP, and BASFI were 5.4 (range, 3.8–7.4), 3.83 (1.4), and 4.0 (range, 2.3–6.2), respectively. The overall FAIR, ASQoL, FSS, HADS-depression, and HADS-anxiety scores were 75 (range, 52–91), 9.6 (5.2), 5.4 (range, 4.1–7), 7.7 (4.4) and 9.6 (5.2), respectively. There were statistically significant correlations between disease activity indices and FAIR, ASQoL, FSS, and HADS scores. The FAIR scores significantly correlated with ASQoL, FSS, and HADS scores. The patients with active disease (BASDAI ≥ 4) had significantly higher levels of FAIR, ASQoL, FSS, and HADS. The best cut-off value for the FAIR score of AS patients with moderate to severe disease activity was 50 (AUC: 0.734, 95% CI [0.599–0.870], P = 0.002), with a sensitivity of 89.8%, specificity of 55%, positive likelihood ratio of 1.99, and Youden index of 0.45.

Conclusion: This study shows that AS patients face a high level of fear which is associated with higher disease activity, higher risk of mood disorders, and lower quality of life. Physicians should not only focus on the physical improvement of the patient but also handle the fear of patients against their diseases and their treatment. This holistic approach will improve the dialogue between the physician and the patient, which will result in increased compliance with treatment and will raise the quality of care.

Downloads

Download data is not yet available.

References

aysal Ö, Durmuş B, Ersoy Y, Altay Z, Şenel K, Nas K, et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatology International. 2011;31(6):795-800. DOI: https://doi.org/10.1007/s00296-010-1381-x

Park JY, Howren AM, Zusman EZ, Esdaile JM, De Vera MA. The incidence of depression and anxiety in patients with ankylosing spondylitis: a systematic review and meta-analysis. BMC Rheumatology. 2020;4(1):1-8. DOI: https://doi.org/10.1186/s41927-019-0111-6

Öncülokur N, Keskin D, Garip Y, Bodur H, Köse K. Turkish version of evaluation of ankylosing spondylitis quality of life questionnaire in patients with ankylosing spondylitis: A validation and reliability study. Archives of Rheumatology. 2018;33(4):443. DOI: https://doi.org/10.5606/ArchRheumatol.2018.6614

Küçükakkaş O, Rezvani A, Yurdakul OV, Tolu S, Kılıçoğlu MS, Aydın T. Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire: a cross-cultural adaptation and validation to the Turkish language. Clinical Rheumatology. 2018;37(12):3247-54. DOI: https://doi.org/10.1007/s10067-018-4239-3

Bedaiwi M, Sari I, Thavaneswaran A, Ayearst R, Haroon N, Inman RD. Fatigue in ankylosing spondylitis and nonradiographic axial spondyloarthritis: analysis from a longitudinal observation cohort. The Journal of Rheumatology. 2015;42(12):2354-60. DOI: https://doi.org/10.3899/jrheum.150463

Belza B. The impact of fatigue on exercise performance. Arthritis & Rheumatism. 1994;7(4):176-80. DOI: https://doi.org/10.1002/art.1790070404

Van Tubergen A, Coenen J, Landewé R, Spoorenberg A, Chorus A, Boonen A, et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Care & Research: Official Journal of the American College of Rheumatology. 2002;47(1):8-16. DOI: https://doi.org/10.1002/art1.10179

Gossec L, Chauvin P, Saraux A, Hudry C, Cukierman G, de Chalus T, et al. Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire. Annals of the Rheumatic Diseases. 2018;77(2):258-63. DOI: https://doi.org/10.1136/annrheumdis-2017-212000

Fallahi S, Jamshidi AR, Bidad K, Qorbani M, Mahmoudi M. Evaluating the reliability of Persian version of ankylosing spondylitis quality of life (ASQoL) questionnaire and related clinical and demographic parameters in patients with ankylosing spondylitis. Rheumatology International. 2014;34(6):803-9. DOI: https://doi.org/10.1007/s00296-013-2888-8

Linden SVD, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis & Rheumatism. 1984;27(4):361-8. DOI: https://doi.org/10.1002/art.1780270401

Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. The Journal of Rheumatology. 1994;21(12):2286-91.

Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 2009;68(1):18-24. DOI: https://doi.org/10.1136/ard.2008.094870

Calin A, Garrett S, Whitelock H, Kennedy LG, O’hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-5.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361-70. DOI: https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

Aydemir Ö, Güvenir T, Küey L, Kultur S. Hospital Anxiety and Depression Scale Turkish form: validation and reliability study. Türk Psikiyatri Der. 1997;8(4):280e7.

Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology. 1989;46(10):1121-3. DOI: https://doi.org/10.1001/archneur.1989.00520460115022

Gencay-Can A, Can SS. Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia. Rheumatology international. 2012;32(1):27-31. DOI: https://doi.org/10.1007/s00296-010-1558-3

Guler T, Garip Y, Dortbas F, Dogan YP. Quality of life in Turkish patients with Familial Mediterranean Fever: Association with fatigue, psychological status, disease severity and other clinical parameters. The Egyptian Rheumatologist. 2018;40(2):117-21. DOI: https://doi.org/10.1016/j.ejr.2017.07.004

Doward L, Spoorenberg A, Cook S, Whalley D, Helliwell P, Kay L, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Annals of the Rheumatic Diseases. 2003;62(1):20-6. DOI: https://doi.org/10.1136/ard.62.1.20

Duruöz M, Doward L, Turan Y, Cerrahoglu L, Yurtkuran M, Calis M, et al. Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatology International. 2013;33(11):2717-22. DOI: https://doi.org/10.1007/s00296-013-2796-y

Berenbaum F, Chauvin P, Hudry C, Mathoret-Philibert F, Poussiere M, De Chalus T, et al. Fears and beliefs in rheumatoid arthritis and spondyloarthritis: A qualitative study. PLoS One. 2014;9(12):e114350. DOI: https://doi.org/10.1371/journal.pone.0114350

Bodur H, Ataman Ş, Rezvani A, Buğdaycı DS, Çevik R, Birtane M, et al. Quality of life and related variables in patients with ankylosing spondylitis. Quality of Life Research. 2011;20(4):543-9. DOI: https://doi.org/10.1007/s11136-010-9771-9

Zhao L, Liao Z, Li C, Li T, Wu J, Lin Q, et al. Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population. Rheumatology International. 2007;27(7):605-11. DOI: https://doi.org/10.1007/s00296-006-0267-4

Pham T, van der Heijde DM, Pouchot J, Guillemin F. Development and validation of the French ASQoL questionnaire. Clin Exp Rheumatol. 2010;28(3):379-85.

Jenks K, Treharne GJ, Garcia J, Stebbings S. The ankylosing spondylitis quality of life questionnaire: validation in a New Zealand cohort. International Journal of Rheumatic Diseases. 2010;13(4):361-6. DOI: https://doi.org/10.1111/j.1756-185X.2010.01554.x

Webers C, Vanhoof L, Leue C, Boonen A, Köhler S. Depression in ankylosing spondylitis and the role of disease-related and contextual factors: a cross-sectional study. Arthritis Research & Therapy. 2019;21(1):1-10. DOI: https://doi.org/10.1186/s13075-019-1995-7

Zhang L, Wu Y, Liu S, Zhu W. Prevalence of depression in ankylosing spondylitis: a systematic review and meta-analysis. Psychiatry Investigation. 2019;16(8):565. DOI: https://doi.org/10.30773/pi.2019.06.05

Shen C-C, Hu L-Y, Yang AC, Kuo BI-T, Chiang Y-Y, Tsai S-J. Risk of psychiatric disorders following ankylosing spondylitis: a nationwide population-based retrospective cohort study. The Journal of Rheumatology. 2016;43(3):625-31. DOI: https://doi.org/10.3899/jrheum.150388

Zhou W, Guo J, He M, Li J, Chen Y, Liu J, et al. Fatigue and contributing factors in Chinese patients with ankylosing spondylitis. Clinical Rheumatology. 2020;39(8):2337-44. DOI: https://doi.org/10.1007/s10067-020-04976-x

Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM. Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self‐reported measures. Arthritis Care & Research. 2005;53(1):5-11. DOI: https://doi.org/10.1002/art.20910

Downloads

Published

2022-07-29

Issue

Section

Research Article

How to Cite

1.
Keleşoğlu Dinçer AB, Sezer S. Association of fear assessment in inflammatory rheumatic diseases (FAIR) questionnaire with ankylosing spondylitis quality of life and disease activity in patients with ankylosing spondylitis: Fear assessment questionnaire in ankylosing spondylitis. J Surg Med [Internet]. 2022 Jul. 29 [cited 2022 Aug. 8];6(7):679-83. Available from: https://jsurgmed.com/article/view/1119839